Concurrent use of palbociclib and radiation therapy: single-centre experience and review of the literature

Palbociclib in combination with endocrine therapy increases progression-free survival in patients with ER-positive, HER2-negative advanced breast cancer (BC). In this study, we retrospectively evaluated safety in the first patient treated with concurrent use of palbociclib and radiation therapy (RT)...

Descripción completa

Detalles Bibliográficos
Autores principales: Beddok, Arnaud, Xu, Hao Ping, Henry, Alexandre Arsène, Porte, Baptiste, Fourquet, Alain, Cottu, Paul, Kirova, Youlia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7493877/
https://www.ncbi.nlm.nih.gov/pubmed/32595213
http://dx.doi.org/10.1038/s41416-020-0957-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7493877/
https://www.ncbi.nlm.nih.gov/pubmed/32595213
http://dx.doi.org/10.1038/s41416-020-0957-9

Ejemplares similares